US Supreme Court ‘skinny label’ arguments focus on pleading standards, not patents
Multiple justices of the US Supreme Court appeared wary on Wednesday of an opinion that would change the standard for induced patent infringement during oral arguments in Hikma Pharmaceuticals v. Amarin...To view the full article, register now.
Already a subscriber? Click here to view full article